Healthcare provider profile · identity verified

Marc L Orgel, MD

Internal Medicine · BRONX, NY · NPI 1447343660

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1002	299
Amlodipine Besylate	Amlodipine Besylate	535	154
Albuterol Sulfate Hfa	Albuterol Sulfate	366	81
Losartan Potassium	Losartan Potassium	320	98
Metoprolol Succinate	Metoprolol Succinate	308	98
Metformin Hcl	Metformin Hcl	292	86
Nifedipine Er	Nifedipine	268	81
Gabapentin	Gabapentin	263	74
Omeprazole	Omeprazole	240	72
Lisinopril	Lisinopril	227	67
Hydrochlorothiazide	Hydrochlorothiazide	214	71
Simvastatin	Simvastatin	211	63
Januvia	Sitagliptin Phosphate	170	39
Levothyroxine Sodium	Levothyroxine Sodium	158	50
Eliquis	Apixaban	156	40
Jardiance	Empagliflozin	154	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	147	35
Glipizide Er	Glipizide	145	40
Fluticasone Propionate	Fluticasone Propionate	144	43
Alendronate Sodium	Alendronate Sodium	132	38
Atenolol	Atenolol	129	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	128	40
Rosuvastatin Calcium	Rosuvastatin Calcium	126	45
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	124	42
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	122	16
Pantoprazole Sodium	Pantoprazole Sodium	120	38
Metformin Hcl Er	Metformin Hcl	118	37
Tamsulosin Hcl	Tamsulosin Hcl	114	38
Famotidine	Famotidine	107	37
Furosemide	Furosemide	106	35
Carvedilol	Carvedilol	104	26
Ibuprofen	Ibuprofen	102	25
Ozempic	Semaglutide	101	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	92	21
Meclizine Hcl	Meclizine Hcl	92	28
Naproxen	Naproxen	91	31
Zolpidem Tartrate	Zolpidem Tartrate	90	13
Oxycodone Hcl	Oxycodone Hcl	87	suppressed
Prednisone	Prednisone	83	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	81	22
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	80	21
Glimepiride	Glimepiride	80	23
Tramadol Hcl	Tramadol Hcl	79	16
Chlorthalidone	Chlorthalidone	75	25
Montelukast Sodium	Montelukast Sodium	75	20
Novolog Flexpen	Insulin Aspart	74	22
Ezetimibe	Ezetimibe	70	19
Triamcinolone Acetonide	Triamcinolone Acetonide	70	30
Ammonium Lactate	Ammonium Lactate	68	19
Diclofenac Sodium	Diclofenac Sodium	64	20
Pravastatin Sodium	Pravastatin Sodium	61	11
Metoprolol Tartrate	Metoprolol Tartrate	59	23
Tizanidine Hcl	Tizanidine Hcl	59	suppressed
Trulicity	Dulaglutide	59	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	58	27
Sertraline Hcl	Sertraline Hcl	58	15
Donepezil Hcl	Donepezil Hcl	56	16
Allopurinol	Allopurinol	50	17
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	50	16
Clopidogrel	Clopidogrel Bisulfate	49	19
Ketoconazole	Ketoconazole	49	18
Mirtazapine	Mirtazapine	49	16
Xarelto	Rivaroxaban	49	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	12
Acetaminophen-Codeine	Acetaminophen With Codeine	47	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	46	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	12
Levetiracetam	Levetiracetam	43	11
Single Use Swab	Alcohol Antiseptic Pads	43	15
Spironolactone	Spironolactone	43	15
Valsartan	Valsartan	43	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	18
Azelastine Hcl	Azelastine Hcl	40	16
Enalapril Maleate	Enalapril Maleate	40	11
Hydralazine Hcl	Hydralazine Hcl	40	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Pregabalin	Pregabalin	39	suppressed
Valacyclovir	Valacyclovir Hcl	39	11
Finasteride	Finasteride	37	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	36	suppressed
Potassium Chloride	Potassium Chloride	35	13
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Indapamide	Indapamide	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	30	12
Baclofen	Baclofen	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Glipizide	Glipizide	28	suppressed
Hydrocortisone	Hydrocortisone	28	11
Meloxicam	Meloxicam	28	11
Nystatin	Nystatin	28	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	11
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ibu	Ibuprofen	24	suppressed
Levemir Flexpen	Insulin Detemir	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Novolin N	Insulin Nph Human Isophane	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Mupirocin	Mupirocin	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Clonidine	Clonidine	19	suppressed
Colchicine	Colchicine	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Fluocinonide	Fluocinonide	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Torsemide	Torsemide	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	16	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Topiramate	Topiramate	15	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Ciclopirox	Ciclopirox Olamine	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Flunisolide	Flunisolide	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Admelog Solostar	Insulin Lispro	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Methimazole	Methimazole	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Sulindac	Sulindac	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Constulose	Lactulose	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Endocet	Oxycodone Hcl/Acetaminophen	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Nabumetone	Nabumetone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error